Document is current
Any future updates will be listed below
-
Authors
Sellés Vidal, Lara https://orcid.org/0000-0003-2537-6824
Murray, James W. https://orcid.org/0000-0002-8897-0161
Heap, John T. https://orcid.org/0000-0001-9991-5160
-
Funding
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/N503873/1, BB/D524840/1)
Wellcome Trust (202926/Z/16/Z)
- License Information
-
More Information
Article History
Received: 8 September 2021
Accepted: 4 November 2021
First Online: 25 November 2021
Competing interests
: J.T.H. and L.S.V. declare the following competing interests: J.T.H. and L.S.V. are named inventors and potential beneficiaries of patent application WO2019243821/EP3810760/US20210277441 (applicant: Imperial College Innovations Limited; status: pending), which covers aspects of this manuscript: the method and enzyme variants CBADH<sub>S</sub>, MsIRED<sub>S</sub>, EntNfsB<sub>S1</sub>, and EntNfsB<sub>S2</sub>. J.T.H. and L.S.V. are named inventors and potential beneficiaries of patent application WO2021099767A1 (applicant: Imperial College Innovations Limited; status: pending) which covers aspects of this manuscript: enzyme variants TBADH<sub>S1</sub> and TBADH<sub>S2</sub>. J.W.M. declares no competing interests.
